Please Note: This trial is no longer enrolling new participants
A program for monitoring minimal residual disease following treatment of patients with Acute Myeloid Leukemia or High Grade Myelodysplastic Syndrome
Protocol No. | CTO-IUSCCC-0883 | Scope | Local |
---|---|---|---|
Principal Investigator | Michael Becker | Treatment Type | Retrospective |
Age Group | Adult | Phase | NA |